UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

OncoCalendar

Loading Events

« All Events

  • This event has passed.

ESMO Advanced Course on Pancreatic Cancer

Nov 7 - Nov 8
ESMO

The ESMO Advanced Course on Pancreatic Cancer: From Standard Treatment to Individualization 2025 is a specialized two-day event scheduled to take place in Zurich, Switzerland, from November 7–8, 2025. The course is designed to provide oncology professionals with an updated, interdisciplinary overview of managing pancreatic cancer. A core goal is to move beyond generalized standards of care by interactively discussing treatment strategies based on patient cases, study data, and the latest ESMO Clinical Practice Guidelines. The course will challenge attendees to “think outside the box” regarding current and future individualized therapy strategies.

The program aims to address the most critical issues in an interdisciplinary way, ensuring participants can apply the information to individual clinical decision-making immediately upon returning to their practice. While the application deadline has closed, confirming the participant list is finalized, the course remains accredited with 9 ESMO-MORA category 1 points for medical oncologists seeking recertification. Non-local participants will be eligible for a travel grant of up to 600 euros to assist with their travel costs to the Zurich venue.

You can find more posts featuring ESMO on OncoDaily.